Reconstitution Steps
- Remove the vial from refrigerator and allow to equilibrate at room temperature for 15–20 minutes.
- Remove plastic safety cap then wipe top of Peptide and Bacteriostactic Water vials with alcohol to disinfect.
- Draw 2.0 mL bacteriostatic water with a sterile syringe. All our vials are vacuum sealed, so when inserting syringe to add bacterioststic water hold plunger so it does not shoot the water into the peptide or vial.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved—solution should be clear (do not shake).
- Refrigerate at 2–8 °C (35.6–46.4 °F).
Cagrilintide (10mg) Research Guide
- Cagrilintide is dosed at 600 mcg–4.5 mg weekly by subcutaneous injection in educational protocols, starting low and titrating upward. This information is for research and educational use only.
- Weeks 1–2: 0.6 mg / 12 units / 0.12 mL
- Weeks 3–4: 1.2 mg / 24 units / 0.24 mL
- Weeks 5–6: 2.4 mg / 48 units / 0.48 mL
- Weeks 7–16 (Maintenance) 4.5 mg / 90 units / .90 mL
Cagrilintide is a long‑acting acylated analogue of the pancreatic hormone amylin, designed for once‑weekly subcutaneous administrationl. It activates central amylin receptors to promote satiety, slow gastric emptying, and reduce food intake In phase 2 and phase 3 trials, cagrilintide produced dose‑dependent weight loss with a predominantly gastrointestinal side‑effect profile.
Important: This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.
